While shedding his formal GP title, the 71-year-old technologist remains tied to the firm’s future. Nilekani will serve as the anchor investor for the new fund and continue his involvement as a strategic advisor and mentor to portfolio founders. Sanjeev Aggarwal, who co-founded the firm with Nilekani in 2017, characterized the move as a shift in administrative role rather than a withdrawal from the firm’s mission.
Fund III represents a significant evolution for the partnership, which has historically focused on Series B and later-stage bets like Spinny and PharmEasy. The new fund plans to issue checks of approximately $10.5 million to eight or ten startups, with a specific interest in AI applications built atop existing global models. The firm is currently raising capital from a mix of domestic and international institutions, reflecting the maturation of the Indian venture landscape. Aggarwal noted that unlike the mid-2000s, when domestic capital was virtually nonexistent, India now possesses the depth to sustain local firms entirely through home-grown funding.





Comments (0)
No comments yet. Be the first!